The 20 Best Midline Lethal Granuloma Doctors Near Me in Duarte, CA

Kanwaldeep Rasila is an Oncologist practicing medicine in Fairfield, California. Dr. Rasila is rated as an Advanced provider by MediFind in the treatment of Midline Lethal Granuloma. She is also highly rated in 55 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Intraductal Papilloma, and Subacute Combined Degeneration. Dr. Rasila is board certified in Medical Oncology - Board Certified and Hematology - Board Certified. Dr. Rasila is currently accepting new patients.

Lauren Maeda is an Oncologist practicing medicine in Palo Alto, California. Dr. Maeda is rated as a Distinguished provider by MediFind in the treatment of Midline Lethal Granuloma. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Midline Lethal Granuloma, Bone Marrow Aspiration, and Gastrostomy.

Robert Lowsky is a Hematologist practicing medicine in Palo Alto, California. Dr. Lowsky is rated as a Distinguished provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Kidney Transplant.

I strive to provide my patients with the best medical care possible. Dr. Murton is rated as an Advanced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Benign Paroxysmal Positional Vertigo, Infant Hearing Loss, Nonsyndromic Hearing Loss, Laryngectomy, and Myringotomy. Dr. Murton is board certified in Otolaryngology. Dr. Murton is currently accepting new patients.

Elias Kiwan is an Oncologist practicing medicine in Sacramento, California. Dr. Kiwan is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 77 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Large-Cell Immunoblastic Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Kiwan is board certified in Medical Oncology - Board Certified , Hematology - Board Certified , and Not ABMS Specialty. Dr. Kiwan is currently accepting new patients.

Born and raised in Hong Kong, Dr. Kevin K. Ho moved to the United States and pursued his undergraduate studies in Biomedical Engineering at Johns Hopkins. He then attended medical school at the University of California., Irvine and graduated with Distinctions in research. His work on electromechanical cartilage reshaping has been published in international journals and granted a US patent (7, 416, 550). Dr. Ho subsequently completed his residency in Otolaryngology, Head and Neck Surgery at the University of Texas Medical Branch.During his five-year residency training, he worked with numerous accomplished surgeons and clinicians, including sub-specialty rotations in the Alaska Native Medical Center and the Houston Texas Center. Dr. Ho is board certified by the American Board of Otolaryngology. Dr. Ho is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Familial Deafness, Infant Hearing Loss, Hearing Loss, and Laryngitis. Dr. Ho is board certified in Otolaryngology. Dr. Ho is currently accepting new patients.

Tatiana Kain is a Radiologist and a Nuclear Medicine provider practicing medicine in Irvine, California. Dr. Kain is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Muscle Invasive Bladder Cancer, Melorheostosis, and Melorheostosis with Osteopoikilosis. Dr. Kain is board certified in American Board Of Nuclear Medicine - Nuclear Medicine and American Board Of Radiology - Diagnostic Radiology.

Dr. Eleanor Chu is a board-certified UCI Health radiologist who specializes in neuroradiology.She earned her medical degree at New York Medical College in Valhalla, N.Y., followed by an internal medicine internship at Santa Clara Valley Medical Center in San jose, Calif. Next, she completed a residency in diagnostic radiology and a fellowship in neuroradiology, both at UCI Medical Center and the UCI School of Medicine's Department of Radiological Sciences. Dr. Chu is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Stroke, Neurofibromatosis Type 2 (NF2), RASopathies, and Neurofibromatosis. Dr. Chu is board certified in American Board Of Radiology - Neuroradiology and American Board Of Radiology - Diagnostic Radiology.

Dr. Houshyar is a fellowship-trained radiologist who specializes in imaging the abdominal and pelvic area in adults, using the latest MRI, CT, ultrasound and X-ray technologies. His clinical interests include genitourinary and liver diseases, as well as cancers of the pancreas and prostate. Dr. Houshyar is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Pelvic Congestion Syndrome, Visceromegaly, Ureterocele, Nephrectomy, and Thrombectomy. Dr. Houshyar is board certified in American Board Of Radiology - Diagnostic Radiology.

Andrew Rezvani is an Oncologist practicing medicine in Palo Alto, California. Dr. Rezvani is rated as an Advanced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Transplant, and Colonoscopy.

"Dr. Lauren C. Pinter-Brown is a board-certified, fellowship-trained UCI hematologist-oncologist who specializes in the diagnosis and treatment of patients with lymphomas.A nationally recognized expert, Pinter-Brown has a longstanding interest in malignant lymphoma, with a particular focus on T-cell and skin lymphomas. Her clinical interests also include antiphospholipid, B-cell lymphoma, Hodgkin's lymphoma, mycosis fungoides, non-Hodgkins lymphoma, stem-cell transplant and Waldenstrom's disease.She her medical degree at the David Geffen School of Medicine at UCLA Medical School, followed by an internship and residency in internal medicine at Harbor-UCLA Medical Center. She completed a fellowship in hematology and oncology at the Keck School of Medicine at USC.A prolific clinical investigator, Pinter-Brown has made important contributions to several clinical trials that led to approval of new drugs for the treatment of T-cell lymphoma. Her research focus is on optimizing treatment options for patients with lymphoma, especially cutaneous and T-cell lymphomas. Her primary goal is to care for patients through diagnosis, treatment and beyond and to ensure that they are able ""to live their best life.""". Dr. Pinter is rated as an Advanced provider by MediFind in the treatment of Midline Lethal Granuloma. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Mycosis Fungoides, Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Transplant. Dr. Pinter is board certified in American Board Of Internal Medicine - Hematology, American Board Of Internal Medicine - Medical Oncology, and American Board Of Internal Medicine - Internal Medicine.

Ranjana Advani is an Oncologist practicing medicine in Palo Alto, California. She has been practicing medicine for over 44 years. Dr. Advani is rated as an Advanced provider by MediFind in the treatment of Midline Lethal Granuloma. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Tissue Biopsy.

Dr. Elizabeth A. Brém is a triple-board certified UCI Health hematologist-oncologist and medical oncologist who specializes in the diagnosis and treatment of lymphoma and other hematologic malignancies.She earned her medical degree magna cum laude from the University at Buffalo Jacobs School of Medicine and Biomedical Sciences in Buffalo, N.Y. She then completed an internal medicine residency and a hematology-oncology fellowship at Beth Israel Deaconess Medical Center in Boston, where she was a clinical fellow at Harvard Medical School. In Boston, she also did research training at the Dana Farber Cancer Institute in the lab of Dr. Anthony Letai, studying the Bcl-2 family of proteins and its role as a therapeutic target and source of therapy resistance in lymphomas.Her research focus is on lymphoma and BCL-2 family proteins in the regulation of apoptosis, or normal cell death. She is an active member of the American Society of Hematology, a member of the Southwest Oncology Group's Lymphoma Working Group and the University of California Hematologic Malignancies Consortium. Her goal is to help design and conduct innovative clinical trials for patients with lymphoma. Dr. Brem is rated as an Advanced provider by MediFind in the treatment of Midline Lethal Granuloma. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Brem is board certified in American Board Of Internal Medicine - Medical Oncology, American Board Of Internal Medicine - Hematology, and American Board Of Internal Medicine - Internal Medicine.

Wen-kai Weng is an Oncologist practicing medicine in Stanford, California. Dr. Weng is rated as an Advanced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Mycosis Fungoides, T-Cell Lymphoma, Graft Versus Host Disease (GvHD), Cutaneous T-Cell Lymphoma (CTCL), and Bone Marrow Transplant.

Dr. Wei Ai is a blood cancer specialist who cares for adults with conditions such as Hodgkin's lymphoma and non-Hodgkin's lymphoma, including cutaneous lymphomas, which primarily involve the skin. She also sees patients needing blood and bone marrow transplantation. In her research, Ai focuses on novel approaches to lymphoma treatment, especially targeted agents for T-cell lymphomas. Her studies often lead to clinical trials of new therapies that target cancer at the molecular level. Ai earned a doctoral degree in microbiology and immunology as well as her medical degree from Stanford University School of Medicine. She completed a residency in internal medicine at UCSF, followed by fellowship training in medical oncology at Stanford. Dr. Ai is rated as an Advanced provider by MediFind in the treatment of Midline Lethal Granuloma. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), T-Cell Lymphoma, Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Ai is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Ai is currently accepting new patients.

Dr. Lawrence D. Kaplan, a hematologist-oncologist, directs UCSF's lymphoma program. He is an international leader in the treatment of lymphoma and HIV-associated lymphoma. In his research, Kaplan is particularly interested in developing new treatments for lymphoma and the HIV-related form of this cancer. Kaplan earned his medical degree at the David Geffen School of Medicine at UCLA. He completed a residency in medicine at Boston Medical Center and completed a fellowship in hematology and oncology at UCSF. He joined UCSF in 1985. Kaplan's professional activities include serving on the Lymphoma Working Group of the AIDS Malignancy Consortium, a clinical trials group supported by the National Cancer Institute (NCI). He formerly chaired the group's steering committee. He also serves on the lymphoma committee of Alliance for Clinical Trials in Oncology, a national research group sponsored by the NCI. Dr. Kaplan is rated as an Advanced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Kaplan is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Kaplan is currently accepting new patients.

Dr. Edward C. Kuan is a board-certified, fellowship-trained UCI Health otolaryngologist who specializes in medical and surgical treatment for disorders of the nose, paranasal sinuses and skull base. He is Co-Director of the UCI Comprehensive Skull Base Program and Chief of Rhinology and Skull Base Surgery.As a rhinologist and skull base surgeon, his clinical practice focuses on complex and revision endoscopic sinus surgery for challenging sinusitis and nasal polyps, especially cases that have failed prior medical and/or surgical therapy. He also has a focused interest in sinonasal tumors and often partners with the UCI Head and Neck Cancer team to provide comprehensive treatment for both benign and malignant tumors of the nose and sinuses, often achievable via a minimally invasive approach.In addition, he performs endoscopic skull base surgery in close collaboration with UCI Health neurosurgeons as part of the UCI Health Skull Base Surgery Program, including removal of brain tumors through the nose and reconstructing defects between the brain and the nose (cerebrospinal fluid leaks and encephaloceles), and frequently collaborates with the UCI Health Facial Plastic Surgery team for the comprehensive surgical treatment of the functional nasal airway.Kuan earned his medical degree at UCI School of Medicine. He completed residency training in otolaryngology at UCLA, followed by a fellowship in rhinology and skull-base surgery at the University of Pennsylvania in Philadelphia.His research interests include bioengineering applications in rhinology, skull base reconstruction, and clinical outcomes of chronic sinusitis, sinonasal tumors and skull base surgery. He has published more than 350 peer-reviewed original articles, reviews and book chaptersin the highest-impact otolaryngology and neurosurgery journals and is a regular invited speaker for both clinical topics and his research nationally and internationally. He is actively involved in the American Rhinologic Society, North American Skull Base Society and Triological Society. He is the primary editor of a textbook on skull base reconstruction and is the primary editor of the International Consensus Statement on Allergy and Rhinology - Sinonasal Tumors document. He also serves as an associate editor and/or on the editorial boards of multiple scientific journals, including all journals focused on the field of rhinology. Dr. Kuan is rated as an Advanced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Sinus Cancer, Olfactory Neuroblastoma, Pituitary Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Endoscopy. Dr. Kuan is board certified in American Board Of Otolaryngology - Head And Neck Surgery - Otolaryngology - Head And Neck Surgery.

Jagruti Shah is a Radiologist practicing medicine in Stanford, California. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses WT1-Related Wilms Tumor Syndromes, Osteopenia, Melorheostosis, and Melorheostosis with Osteopoikilosis.

Brian Dicarlo is an Oncologist practicing medicine in San Luis Obispo, California. Dr. Dicarlo is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Paget Disease of the Breast, Lung Cancer, and Large-Cell Immunoblastic Lymphoma. Dr. Dicarlo is board certified in Internal Medicine (Sub: Hematology) and Internal Medicine (Sub: Medical Oncology). Dr. Dicarlo is currently accepting new patients.

Kip Guja is a Radiologist practicing medicine in Palo Alto, California. Dr. Guja is rated as an Experienced provider by MediFind in the treatment of Midline Lethal Granuloma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Melorheostosis, Melorheostosis with Osteopoikilosis, Osteopenia, and Tissue Biopsy.